Salisbury Foundation Trust

FOI_5704

Internal Reference Number: FOI_5704

Date Request Received: 22/06/2020 10:04:09

Date Request Replied To: 03/08/2020 08:35:44

This response was sent via: By Email

Request Summary: Ophthalmology new patients

Request Category: Companies

 
Question Number 1:
Within your Trust, how many patients, in the most recent 12-month period for which data are available, have received anti-VEGF treatment for the first time (i.e., excluding patients who previously had any anti-VEGF therapy)?
 
Answer To Question 1:
247 patients underwent their first anti-VEGF treatment
 
Question Number 2:
Of these first-time patients, please provide a breakdown by the treatments listed below:
Aflibercept
Brolucizumab
Dexamethasone
Ranibizumab
All other anti-VEGF treatments
 
Answer To Question 2:
Aflibercept 222
Brolucizumab 0
Dexamethasone 0
Ranibizumab 19
All other antiVEGF treatments 6
 
Question Number 3:
Of these first-time patients, how many were treated for Wet Age-Related Macular Degeneration (wAMD) by each treatment?
Aflibercept
Brolucizumab
Dexamethasone
Ranibizumab
All Other anti-VEGF treatments
 
Answer To Question 3:
Aflibercept 158
Brolucizumab 0 - still waiting FDA approval
Dexamethasone 0 - not an antiVEGF and therefore not used for the treatment of wet AMD
Ranibizumab 16
All other antiVEGF treatments 2

 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2021 Salisbury NHS Foundation Trust
Trust Values